Australia markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
39.74+0.99 (+2.55%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 55.17B
Enterprise value 34.41B
Trailing P/E N/A
Forward P/E 1-86.39
PEG ratio (5-yr expected) 1-2.89
Price/sales (ttm)67.67
Price/book (mrq)N/A
Enterprise value/revenue 357.80
Enterprise value/EBITDA 7-16.78

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 326.18%
S&P500 52-week change 348.53%
52-week high 3141.01
52-week low 325.31
50-day moving average 347.11
200-day moving average 344.12

Share statistics

Avg vol (3-month) 31.19M
Avg vol (10-day) 3659.47k
Shares outstanding 5130.04M
Implied shares outstanding 6N/A
Float 63.38M
% held by insiders 113.87%
% held by institutions 181.07%
Shares short (29 Apr 2021) 48.39M
Short ratio (29 Apr 2021) 412.65
Short % of float (29 Apr 2021) 412.19%
Short % of shares outstanding (29 Apr 2021) 46.46%
Shares short (prior month 30 Mar 2021) 47.91M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-350.21%

Management effectiveness

Return on assets (ttm)-23.36%
Return on equity (ttm)-52.36%

Income statement

Revenue (ttm)76.37M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)76.90%
Gross profit (ttm)-196.51M
EBITDA -263.01M
Net income avi to common (ttm)-298.66M
Diluted EPS (ttm)-14.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)736.86M
Total cash per share (mrq)5.76
Total debt (mrq)70.45M
Total debt/equity (mrq)9.83
Current ratio (mrq)7.80
Book value per share (mrq)-23.94

Cash flow statement

Operating cash flow (ttm)-190.94M
Levered free cash flow (ttm)-120.4M